Department of Urology, Universidad Autónoma de Nuevo León , Monterrey , Mexico.
Hospital Universitario Dr. José Eleuterio González and Faculty of Medicine, Universidad Autónoma de Nuevo León , Monterrey , Mexico.
J Urol. 2019 Jul;202(1):153-158. doi: 10.1097/JU.0000000000000244. Epub 2019 Jun 7.
Urinary tract infections are common and severe complications in patients with spina bifida. Management includes intermittent bladder catheterization with single use or reused sterile catheters. There is insufficient evidence to set a standard among the different techniques. We determined whether single use polyvinylchloride catheters would reduce urinary tract infections compared to reused polyvinylchloride catheters in patients with neurogenic bladder due to spina bifida.
We performed a 2-arm randomized parallel clinical trial from 2015 to 2016 with an 8-week followup at our center in patients with neurogenic bladder caused by spina bifida. Patients were divided into single use and reused polyvinylchloride catheter groups. Evaluations were done on days 0, 7, 14, 28, 42 and 56. Participants reported symptoms and urine cultures were obtained. The primary outcome was urinary tract infection frequency, defined as positive urine culture plus fever, flank pain, malaise, or cloudy or odorous urine. Study eligibility criteria were age 2 years or greater, spina bifida diagnosis with regular clean intermittent bladder catheterization and no urinary tract infection at initial evaluation.
The calculated sample size was 75. Of the patients 135 were screened, 83 were randomized and 75 completed followup. Mean age was 12.7 years (range 2-56) and there were 29 males and 46 females. No statistical difference was found between the single use vs reused catheter groups in the frequency of asymptomatic bacteriuria (32.4% vs 23.7%, p = 0.398) or urinary tract infections (35.2% vs 36.8%, p = 0.877).
Single use polyvinylchloride catheters for intermittent bladder catheterization did not decrease the incidence of urinary tract infections in our patients with neurogenic bladder compared to reused polyvinylchloride catheters. These results are consistent with the 2014 Cochrane Review.
尿路感染是脊柱裂患者常见且严重的并发症。其治疗包括间歇性导尿,使用一次性或重复使用的无菌导尿管。目前尚无充分证据可以在不同技术之间制定标准。我们旨在确定与重复使用的聚氯乙烯(PVC)导尿管相比,在因脊柱裂导致神经源性膀胱的患者中使用一次性聚氯乙烯导尿管是否会降低尿路感染的发生率。
我们于 2015 年至 2016 年在我们的中心进行了一项双臂随机平行临床试验,对因脊柱裂导致神经源性膀胱的患者进行为期 8 周的随访。患者被分为一次性使用 PVC 导管组和重复使用 PVC 导管组。在第 0、7、14、28、42 和 56 天进行评估。参与者报告症状并采集尿液培养。主要结局是尿路感染的发生频率,定义为阳性尿液培养合并发热、肋脊角痛、不适或尿液混浊或有异味。研究纳入标准为年龄≥2 岁、脊柱裂诊断明确、规律行间歇性清洁导尿且初始评估时无尿路感染。
计算的样本量为 75 例。135 例患者接受了筛选,83 例患者被随机分配,75 例患者完成了随访。患者的平均年龄为 12.7 岁(范围 2-56 岁),其中男 29 例,女 46 例。在无症状菌尿(32.4%比 23.7%,p=0.398)或尿路感染(35.2%比 36.8%,p=0.877)的发生率方面,一次性使用导管组与重复使用导管组之间无统计学差异。
与重复使用的 PVC 导尿管相比,间歇性导尿时使用一次性聚氯乙烯导管并未降低我们的神经源性膀胱患者尿路感染的发生率。这些结果与 2014 年 Cochrane 综述一致。